DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Maximize Patient Engagement in Rare and Orphan Disease Clinical Trials
While it may seem obvious that clinical trials for rare and orphan disease groups are the ...
4 Key Ingredients Of A Robust Risk Management Framework
This article was originally published on May 16th, 2019, in Clinical Leader.
“If This Is True” – What Does This Mean for Clinical Trials?
On March 19, 2019, the FDA released an Impact Story with implications for nearly everyone ...
Reflections on Rare Disease Day 2019
I had the pleasure of attending MassBio’s 2019 Rare Disease Day event – a day which (I ...
Apple Watch Approval Marks Shift In Device Development And Approvals
In September, the U.S. Food and Drug Administration (FDA) approved the Apple Watch’s ...
Regulatory And Clinical Strategic Planning For Cell And Gene Therapies
A successful Initial Targeted Engagement for Regulatory Advice on CBER products ...
NIH RAC Changes
The changes to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee ...
Halloran Makes the Inc. 5000 for the Fifth Year in a Row
We are thrilled to announce that Halloran has been recognized on the Inc. 5000 list for ...
Halloran Receives Two NEDMA Awards for Creative Excellence
We are thrilled to announce that the New England Direct Marketing Association (NEDMA) has ...
How to Prevent Clinical Trial Protocol Deviations
Click here to read the full article.